These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202 [TBL] [Abstract][Full Text] [Related]
9. Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins. Steiner H; Winkler E; Shearman MS; Prywes R; Haass C Neurobiol Dis; 2001 Aug; 8(4):717-22. PubMed ID: 11493036 [TBL] [Abstract][Full Text] [Related]
10. Identification of IQM-266, a Novel DREAM Ligand That Modulates K Peraza DA; Cercós P; Miaja P; Merinero YG; Lagartera L; Socuéllamos PG; Izquierdo García C; Sánchez SA; López-Hurtado A; Martín-Martínez M; Olivos-Oré LA; Naranjo JR; Artalejo AR; Gutiérrez-Rodríguez M; Valenzuela C Front Mol Neurosci; 2019; 12():11. PubMed ID: 30787866 [TBL] [Abstract][Full Text] [Related]
11. Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington's disease treatment. Lopez-Hurtado A; Peraza DA; Cercos P; Lagartera L; Gonzalez P; Dopazo XM; Herranz R; Gonzalez T; Martin-Martinez M; Mellström B; Naranjo JR; Valenzuela C; Gutierrez-Rodriguez M Sci Rep; 2019 May; 9(1):7260. PubMed ID: 31086218 [TBL] [Abstract][Full Text] [Related]
12. Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease. Naranjo JR; Zhang H; Villar D; González P; Dopazo XM; Morón-Oset J; Higueras E; Oliveros JC; Arrabal MD; Prieto A; Cercós P; González T; De la Cruz A; Casado-Vela J; Rábano A; Valenzuela C; Gutierrez-Rodriguez M; Li JY; Mellström B J Clin Invest; 2016 Feb; 126(2):627-38. PubMed ID: 26752648 [TBL] [Abstract][Full Text] [Related]
13. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Buxbaum JD; Choi EK; Luo Y; Lilliehook C; Crowley AC; Merriam DE; Wasco W Nat Med; 1998 Oct; 4(10):1177-81. PubMed ID: 9771752 [TBL] [Abstract][Full Text] [Related]
14. DREAM controls the on/off switch of specific activity-dependent transcription pathways. Mellström B; Sahún I; Ruiz-Nuño A; Murtra P; Gomez-Villafuertes R; Savignac M; Oliveros JC; Gonzalez P; Kastanauskaite A; Knafo S; Zhuo M; Higuera-Matas A; Errington ML; Maldonado R; DeFelipe J; Jefferys JG; Bliss TV; Dierssen M; Naranjo JR Mol Cell Biol; 2014 Mar; 34(5):877-87. PubMed ID: 24366545 [TBL] [Abstract][Full Text] [Related]
15. Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2. Ford DL; Monteiro MJ Biochemistry; 2007 Jul; 46(30):8827-37. PubMed ID: 17614368 [TBL] [Abstract][Full Text] [Related]
16. Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells. Rivabene R; Visentin S; Piscopo P; De Nuccio C; Crestini A; Svetoni F; Rosa P; Confaloni A Exp Biol Med (Maywood); 2014 Feb; 239(2):213-24. PubMed ID: 24363250 [TBL] [Abstract][Full Text] [Related]